Indigocarmine Injection 20mg “AFP” (Indigocarmine Injection “AFP”® / インジゴカルミン注20mg「AFP」)

JPY ¥3,200

Japanese Renal Function Test / Sentinel Lymph Node Mapping Agent (Indigocarmine 20mg/5mL). For intravenous or subcutaneous/intradermal use in renal function testing and sentinel lymph node identification in breast cancer and malignant melanoma. 5mL x 10 ampoules (amber). Mfd. by Alfresa Pharma Corporation, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥2,944
10 - 19 12% JPY ¥2,816
20 + 18% JPY ¥2,624
SKU: IND-20-INJ Category:

Description

Product Overview / 商品概要

Indigocarmine Injection 20mg “AFP” (インジゴカルミン注20mg「AFP」)
Generic: Indigocarmine / インジゴカルミン
Therapeutic Category: Renal Function Test Agent / Sentinel Lymph Node Mapping Agent / 腎機能検査用薬、センチネルリンパ節同定薬
Manufactured by: Alfresa Pharma Corporation / アルフレッサ ファーマ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Indigocarmine (JP) 20mg (0.4 W/V%) per 1 ampoule (5mL) / 1アンプル(5mL)中 インジゴカルミン(日局)20mg(0.4W/V%)
Additives: Glacial acetic acid / 氷酢酸
Appearance: Dark blue liquid
外観: 暗青色の液

Indications / 効能効果

EN: Renal function test (split renal function measurement); Identification of sentinel lymph nodes in the following diseases: breast cancer, malignant melanoma
JA: ○腎機能検査(分腎機能測定による)
○次の疾患におけるセンチネルリンパ節の同定
乳癌、悪性黒色腫

Dosage and Administration / 用法用量

EN: [Renal Function Test] Administer 20–40mg (5–10mL) of indigocarmine by intravenous injection, then examine initial excretion time by cystoscopy.
[Sentinel Lymph Node Identification] For breast cancer: administer up to 20mg (5mL) subcutaneously near the malignant tumor or in the areolar region, divided as appropriate. For malignant melanoma: administer 4–12mg (1–3mL) intradermally at several sites near the malignant tumor, divided as appropriate.
JA: 〈腎機能検査〉通常インジゴカルミンとして20~40mg(5~10mL)を静注した後、膀胱鏡で初排泄時間を調べる。
〈センチネルリンパ節の同定〉乳癌のセンチネルリンパ節の同定においては、インジゴカルミンとして通常20mg(5mL)以下を悪性腫瘍近傍又は乳輪部の皮下に適宜分割して投与する。悪性黒色腫のセンチネルリンパ節の同定においては、インジゴカルミンとして通常4~12mg(1~3mL)を悪性腫瘍近傍の皮内数箇所に適宜分割して投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22100AMX01014
Sales Started: September 1951 / 1951年9月
Classification Code: 877225、87729
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 5mL x 10 ampoules (amber) / 5mL×10アンプル(褐色)
Other Available Packages (by special order): 5mL [10 ampoules (amber)]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Indigocarmine Injection 20mg “AFP” (Indigocarmine Injection “AFP”® / インジゴカルミン注20mg「AFP」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Indigocarmine Injection 20mg "AFP" (Indigocarmine Injection "AFP"®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.